• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Core Scientific Inc.

    2/1/24 4:05:38 PM ET
    $CORZ
    Finance: Consumer Services
    Finance
    Get the next $CORZ alert in real time by email
    SC 13G 1 tm244829d1_sc13g.htm SC 13G

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

      

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. ____)*

      

    Core Scientific, Inc.

    (Name of Issuer)

     

    Common Stock, $0.00001 par value per share

    (Title of Class of Securities)

     

    21874A106

    (CUSIP Number)

     

    January 23, 2024

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨Rule 13d-1(b)

     

    xRule 13d-1(c)

     

    ¨Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     Page 1 of 13 Pages 

     

     

    CUSIP No. 21874A106

     

    1.Names of Reporting Persons

     

    Ibex Investors LLC

     

    2.Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)¨
    (b)x

     

    3.SEC Use Only

     

    4.Citizenship or Place of Organization

     

    Colorado, USA

     

    NUMBER OF SHARES
    BENEFICIALLY OWNED
    BY EACH REPORTING
    PERSON WITH:
    5.  SOLE VOTING POWER 4,833,690
    6.  SHARED VOTING POWER 0
    7.  SOLE DISPOSITIVE POWER 4,833,690
    8.  SHARED DISPOSITIVE POWER 0

     

    9.Aggregate Amount Beneficially Owned by Each Reporting Person

     

    4,833,690

     

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

     

    11.Percent of Class Represented by Amount in Row (9)

     

    2.5%

     

    12.Type of Reporting Person (See Instructions)

     

    OO

     

    ______________

     

    The information above is given as of the end of business on February 1, 2024, the filing date of this Schedule 13G.

     

     Page 2 of 13 Pages 

     

     

    CUSIP No. 21874A106

     

    1.Names of Reporting Persons

     

    Justin B. Borus

     

    2.Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)¨
    (b)x

     

    3.SEC Use Only

     

    4.Citizenship or Place of Organization

     

    USA

     

    NUMBER OF SHARES
    BENEFICIALLY OWNED
    BY EACH REPORTING
    PERSON WITH:
    5.  SOLE VOTING POWER 4,882,796
    6.  SHARED VOTING POWER 0
    7.  SOLE DISPOSITIVE POWER 4,882,796
    8.  SHARED DISPOSITIVE POWER 0

      

    9.Aggregate Amount Beneficially Owned by Each Reporting Person

     

    4,882,796

     

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

     

    11.Percent of Class Represented by Amount in Row (9)

     

    2.6%

     

    12.Type of Reporting Person (See Instructions)

     

    IN

     

    ______________

     

    The information above is given as of the end of business on February 1, 2024, the filing date of this Schedule 13G.

     

     Page 3 of 13 Pages 

     

     

    CUSIP No. 21874A106

     

    1.Names of Reporting Persons

     

    Ibex Partners (Core) LP

     

    2.Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)¨
    (b)x

     

    3.SEC Use Only

     

    4.Citizenship or Place of Organization

     

    Delaware, USA

     

    NUMBER OF SHARES
    BENEFICIALLY OWNED
    BY EACH REPORTING
    PERSON WITH:
    5.  SOLE VOTING POWER    4,813,877
    6.  SHARED VOTING POWER 0
    7.  SOLE DISPOSITIVE POWER    4,813,877
    8.  SHARED DISPOSITIVE POWER 0

      

    9.Aggregate Amount Beneficially Owned by Each Reporting Person

     

    4,813,877

     

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

     

    11.Percent of Class Represented by Amount in Row (9)

     

    2.5%

     

    12.Type of Reporting Person (See Instructions)

     

    PN

     

    ______________

     

    The information above is given as of the end of business on February 1, 2024, the filing date of this Schedule 13G.

      

     Page 4 of 13 Pages 

     

     

     CUSIP No. 21874A106

     

    1.Names of Reporting Persons

     

    Ibex GP LLC

     

    2.Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)¨
    (b)x

     

    3.SEC Use Only

     

    4.Citizenship or Place of Organization

     

    Colorado, USA

     

    NUMBER OF SHARES
    BENEFICIALLY OWNED
    BY EACH REPORTING
    PERSON WITH:
    5.  SOLE VOTING POWER 4,813,877
    6.  SHARED VOTING POWER 0
    7.  SOLE DISPOSITIVE POWER 4,813,877
    8.  SHARED DISPOSITIVE POWER 0

      

    9.Aggregate Amount Beneficially Owned by Each Reporting Person

     

    4,813,877

     

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

     

    11.Percent of Class Represented by Amount in Row (9)

     

    2.5%

     

    12.Type of Reporting Person (See Instructions)

     

    OO

     

    ______________

     

    The information above is given as of the end of business on February 1, 2024, the filing date of this Schedule 13G

     

     Page 5 of 13 Pages 

     

     

     CUSIP No. 21874A106

     

    1.Names of Reporting Persons

     

    Ibex Investment Holdings LLC

     

    2.Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)¨
    (b)x

     

    3.SEC Use Only

     

    4.Citizenship or Place of Organization

     

    Delaware, USA

     

    NUMBER OF SHARES
    BENEFICIALLY OWNED
    BY EACH REPORTING
    PERSON WITH:
    5.  SOLE VOTING POWER 4,833,690
    6.  SHARED VOTING POWER 0
    7.  SOLE DISPOSITIVE POWER 4,833,690
    8.  SHARED DISPOSITIVE POWER 0

      

    9.Aggregate Amount Beneficially Owned by Each Reporting Person

     

    4,833,690

     

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

     

    11.Percent of Class Represented by Amount in Row (9)

     

    2.5%

     

    12.Type of Reporting Person (See Instructions)

     

    OO

     

    ______________

     

    The information above is given as of the end of business on February 1, 2024, the filing date of this Schedule 13G.

     

     Page 6 of 13 Pages 

     

     

    CUSIP No. 21874A106

     

    1.Names of Reporting Persons

     

    Ibex Investment Holdings II LLC

     

    2.Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)¨
    (b)x

     

    3.SEC Use Only

     

    4.Citizenship or Place of Organization

     

    Delaware, USA

     

    NUMBER OF SHARES
    BENEFICIALLY OWNED
    BY EACH REPORTING
    PERSON WITH:
    5.  SOLE VOTING POWER 4,813,877
    6.  SHARED VOTING POWER 0
    7.  SOLE DISPOSITIVE POWER 4,813,877
    8.  SHARED DISPOSITIVE POWER 0

       

    9.Aggregate Amount Beneficially Owned by Each Reporting Person

     

    4,813,877

     

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

     

    11.Percent of Class Represented by Amount in Row (9)

     

    2.5%

     

    12.Type of Reporting Person (See Instructions)

     

    OO

     

    ______________

     

    The information above is given as of the end of business on February 1, 2024, the filing date of this Schedule 13G.

     

     Page 7 of 13 Pages 

     

     

    EXPLANATORY NOTE

     

    In connection with the effectiveness of the Issuer’s Chapter 11 Plan of Reorganization on January 23, 2024, the Fund received: (x) 6,571,239 shares of the Issuer’s new common stock, par value $0.00001 per share (the “Common Stock”); and (y) certain notes convertible into 4,813,877 shares of Common Stock.

     

    On January 24, 2024, the Fund declared a distribution of, and its partners became the beneficial owners of, the aforementioned 6,571,239 shares of Common Stock, including 49,106 shares that became beneficially owned by Mr. Borus and 19,813 shares that became beneficially owned by the Investment Manager.

     

    Item 1.

     

    (a)The name of the issuer is Core Scientific, Inc. (the “Issuer”).

     

    (b)The principal executive offices of the Issuer are located at 210 Barton Springs Road, Suite 300, Austin, TX 78704.

     

    Item 2.

     

    (a)

    This Schedule 13G (this “Statement” or this “Schedule 13G”) is being filed by: (1) Justin B. Borus (“Mr. Borus”); (2) Ibex Investors LLC, a Colorado limited liability company (the “Investment Manager”); (3) Ibex Partners (Core) LP, a Delaware limited partnership (the “Fund”); (4) Ibex GP LLC, a Colorado limited liability company (the “General Partner”); (5) Ibex Investment Holdings LLC, a Delaware limited liability company (“IM Holdings”); and (6) Ibex Investment Holdings II LLC, a Delaware limited liability company (“GP Holdings”) (all of the foregoing, collectively, the “Reporting Persons”).

     

    The Fund is a private investment vehicle. The Investment Manager is the investment manager of the Fund. IM Holdings is the sole member of the Investment Manager. The General Partner is the general partner of the Fund. GP Holdings is the sole member of the General Partner. Mr. Borus is the manager of the Investment Manager, IM Holdings, the General Partner and GP Holdings.

     

    The Fund directly beneficially owns the Common Stock (as defined below) reported herein (other than 49,106 shares of Common Stock owned by Mr. Borus and 19,813 shares of Common Stock owned by the Investment Manager, in each case as of the date of filing of this Schedule 13G).

     

    Mr. Borus, the Investment Manager, IM Holdings, the General Partner and GP Holdings may be deemed to beneficially own the Common Stock that is directly beneficially owned by the Fund. Mr. Borus and IM Holdings may be deemed to beneficially own the Common Stock that is directly beneficially owned by the Investment Manager.

     

    Each Reporting Person disclaims beneficial ownership with respect to any Common Stock other than the Common Stock directly beneficially owned by such Reporting Person.

     

     Page 8 of 13 Pages 

     

     

    (b)The principal business office of the Reporting Persons is c/o Ibex Investors LLC, 260 N. Josephine Street, Suite 300, Denver, CO 80206.

     

    (c)For citizenship information see Item 4 of the cover page of each Reporting Person.

     

    (d)This Statement relates to the new common stock, $0.00001 par value per share, of the Issuer (the “Common Stock”).

     

    (e)The CUSIP Number of the Common Stock is 21874A106.

     

    Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

      (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
      (b) ¨  Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
      (c) ¨  Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
      (d) ¨  Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
      (e) ¨  An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
      (f) ¨  An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);
      (g) ¨  A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);
      (h) ¨  A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
      (i) ¨  A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
      (j) ¨  A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
      (k) ¨  Group, in accordance with §240.13d-1(b)(1)(ii)(K).

     

    If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: ______________________

     

    Item 4. Ownership.

     

    See Items 5-9 and 11 on the cover page for each Reporting Person, and Item 2, which information is given as of the end of business on February 1, 2024, being the date of filing of this Schedule 13G, and consists of: (x) 4,813,877 shares of Common Stock issuable upon the conversion of certain convertible notes owned by the Fund; (y) 49,106 shares of Common Stock owned by Mr. Borus; and (z) 19,813 shares of Common Stock owned by the Investment Manager.

     

     Page 9 of 13 Pages 

     

     

    As of the end of business on the Event Date of January 23, 2024, the Fund directly beneficially owned 11,385,116 shares of Common Stock (consisting of 6,571,239 shares of Common Stock and 4,813,877 shares of Common Stock issuable upon the conversion of certain convertible notes), together representing 6.0% of all of the outstanding Common Stock.

     

    The percentages of beneficial ownership contained herein are based on: (x) 184,998,580 shares of Common Stock outstanding as of January 23, 2024, as obtained by the Reporting Persons directly form the Issuer; and (y) 4,813,877 shares of Common Stock issuable upon the conversion of the convertible notes described above.

     

    Item 5. Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ☒

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

     

    Not applicable.

     

    Item 8. Identification and Classification of Members of the Group.

     

    Not applicable.

     

    Item 9. Notice of Dissolution of Group.

     

    Not applicable.

     

    Item 10. Certification.

     

    (a)Not applicable.

     

    (b)Not applicable.

     

    (c)By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

     

     Page 10 of 13 Pages 

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: February 1, 2024

     

    Justin B. Borus

    Ibex Investors LLC

    Ibex Partners (Core) LP

    Ibex GP LLC

    Ibex Investment Holdings LLC

    Ibex Investment Holdings II LLC

     

    By: /s/ Justin B. Borus  
     

    Justin B. Borus, for himself and as the Manager of each of the Investment Manager, IM Holdings, the General Partner (for itself

    and on behalf of the Fund) and GP Holdings

     

      

     Page 11 of 13 Pages 

     

     

    EXHIBIT INDEX

     

    Exhibit No. Document

     

    1Joint Filing Agreement

     

     Page 12 of 13 Pages 

    Get the next $CORZ alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CORZ

    DatePrice TargetRatingAnalyst
    1/27/2025$22.00Outperform
    Keefe Bruyette
    1/21/2025$24.00Buy
    Craig Hallum
    11/15/2024$25.50Buy
    ROTH MKM
    10/28/2024$19.00Buy
    Jefferies
    9/25/2024$16.00Outperform
    Macquarie
    9/23/2024$16.00Buy
    Canaccord Genuity
    9/4/2024$16.00Buy
    Needham
    7/17/2024$20.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $CORZ
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Core Scientific Announces Departure of Board Member Todd Becker

      Core Scientific, Inc. (NASDAQ:CORZ), a leader in digital infrastructure for high-density colocation services and digital asset mining, today announced that Todd Becker will be stepping down from its Board of Directors, effective immediately. Mr. Becker joined the Board in January 2024 and has served as Chair of the Audit Committee. During his tenure, he provided critical leadership and oversight as Core Scientific completed two significant capital raises that materially improved the company's balance sheet, the hiring of a new Chief Financial Officer and supported its ongoing operational and strategic objectives following its emergence from bankruptcy. His financial acumen and disciplined

      5/13/25 4:42:00 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • Core Scientific Announces Fiscal First Quarter 2025 Results

      First Quarter 2025 Highlights On track to deliver 250MW of billable capacity to CoreWeave by the end of this year and anticipate entering 2026 with annualized colocation revenue of approximately $360 million. First tranche of 8MW of billable capacity at Denton to be delivered to CoreWeave by the end of this month and an additional approximately 40MW by the end of this quarter. Ended the quarter with a strong liquidity position, including $778.6 million in cash and cash equivalents and digital assets, maintaining financial flexibility to execute on strategic organic and inorganic growth opportunities. Core Scientific, Inc. (NASDAQ:CORZ), a leader in digital infrastructure for high-de

      5/7/25 4:05:00 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • Core Scientific, Inc. Schedules First Quarter Fiscal Year 2025 Earnings Release, Conference Call and Webcast

      Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or "the Company"), a leader in digital infrastructure for high-performance computing and bitcoin mining, today announced it will issue financial results for the Company's fiscal year 2025 first quarter after financial markets close on Wednesday, May 7, 2025. Management will host a conference call and live audio webcast to discuss the results at 3:30 p.m. Central Time. Hosting the call and webcast to review results for the first quarter 2025 will be Adam Sullivan, Chief Executive Officer, Jim Nygaard, Chief Financial Officer, and Jon Charbonneau, Vice President, Investor Relations. Conference Call and Webcast Event Summary Date: May 7

      4/24/25 4:10:00 PM ET
      $CORZ
      Finance: Consumer Services
      Finance

    $CORZ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Weiss Eric Stanton bought $50,750 worth of shares (6,000 units at $8.46), increasing direct ownership by 3% to 221,687 units (SEC Form 4)

      4 - Core Scientific, Inc./tx (0001839341) (Issuer)

      3/7/25 3:07:00 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • Director Levy Jordan bought $500,506 worth of shares (62,500 units at $8.01), increasing direct ownership by 26% to 306,887 units (SEC Form 4)

      4 - Core Scientific, Inc./tx (0001839341) (Issuer)

      3/6/25 6:45:04 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • Director Patten Jarrod M bought $24,752 worth of shares (2,240 units at $11.05), increasing direct ownership by 0.75% to 300,000 units (SEC Form 4)

      4 - Core Scientific, Inc./tx (0001839341) (Issuer)

      9/16/24 7:20:51 PM ET
      $CORZ
      Finance: Consumer Services
      Finance

    $CORZ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Officer Duchene Todd M was granted 194,600 shares, increasing direct ownership by 10% to 2,210,102 units (SEC Form 4)

      4 - Core Scientific, Inc./tx (0001839341) (Issuer)

      4/30/25 7:34:10 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • Chief Executive Officer Sullivan Adam Taylor was granted 665,985 shares, increasing direct ownership by 18% to 4,402,149 units (SEC Form 4)

      4 - Core Scientific, Inc./tx (0001839341) (Issuer)

      4/30/25 7:33:58 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • Chief Executive Officer Sullivan Adam Taylor sold $170,213 worth of shares (22,629 units at $7.52), decreasing direct ownership by 0.60% to 3,736,164 units (SEC Form 4)

      4 - Core Scientific, Inc./tx (0001839341) (Issuer)

      4/2/25 4:27:41 PM ET
      $CORZ
      Finance: Consumer Services
      Finance

    $CORZ
    Financials

    Live finance-specific insights

    See more
    • Core Scientific Announces Fiscal First Quarter 2025 Results

      First Quarter 2025 Highlights On track to deliver 250MW of billable capacity to CoreWeave by the end of this year and anticipate entering 2026 with annualized colocation revenue of approximately $360 million. First tranche of 8MW of billable capacity at Denton to be delivered to CoreWeave by the end of this month and an additional approximately 40MW by the end of this quarter. Ended the quarter with a strong liquidity position, including $778.6 million in cash and cash equivalents and digital assets, maintaining financial flexibility to execute on strategic organic and inorganic growth opportunities. Core Scientific, Inc. (NASDAQ:CORZ), a leader in digital infrastructure for high-de

      5/7/25 4:05:00 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • Core Scientific, Inc. Schedules First Quarter Fiscal Year 2025 Earnings Release, Conference Call and Webcast

      Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or "the Company"), a leader in digital infrastructure for high-performance computing and bitcoin mining, today announced it will issue financial results for the Company's fiscal year 2025 first quarter after financial markets close on Wednesday, May 7, 2025. Management will host a conference call and live audio webcast to discuss the results at 3:30 p.m. Central Time. Hosting the call and webcast to review results for the first quarter 2025 will be Adam Sullivan, Chief Executive Officer, Jim Nygaard, Chief Financial Officer, and Jon Charbonneau, Vice President, Investor Relations. Conference Call and Webcast Event Summary Date: May 7

      4/24/25 4:10:00 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • Core Scientific Announces Fiscal Fourth Quarter and Full Fiscal Year 2024 Results

      Fourth Quarter 2024 Highlights Incurred net loss of $265.5 million due primarily to a $224.7 million non-cash mark-to-market adjustment to warrants and other contingent value right liabilities required by the significant year-over-year increase in our share price Reported operating loss of $39.8 million, a decrease of $43.7 million over fourth quarter 2023 Generated adjusted EBITDA of $13.3 million, a decrease of $43.4 million over fourth quarter 2023 Secured $625 million through a convertible note offering with favorable 0% interest terms Strengthened the balance sheet, ending the quarter with cash and cash equivalents of $836.2 million as of December 31, 2024 Earned 974

      2/26/25 4:05:00 PM ET
      $CORZ
      Finance: Consumer Services
      Finance

    $CORZ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Core Scientific Inc.

      SC 13G - Core Scientific, Inc./tx (0001839341) (Subject)

      8/19/24 7:14:21 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • SEC Form SC 13D/A filed by Core Scientific Inc. (Amendment)

      SC 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)

      2/21/24 4:43:56 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • SEC Form SC 13D/A filed by Core Scientific Inc. (Amendment)

      SC 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)

      2/20/24 5:19:03 PM ET
      $CORZ
      Finance: Consumer Services
      Finance

    $CORZ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Keefe Bruyette initiated coverage on Core Scientific with a new price target

      Keefe Bruyette initiated coverage of Core Scientific with a rating of Outperform and set a new price target of $22.00

      1/27/25 7:37:53 AM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • Craig Hallum initiated coverage on Core Scientific with a new price target

      Craig Hallum initiated coverage of Core Scientific with a rating of Buy and set a new price target of $24.00

      1/21/25 8:43:19 AM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • ROTH MKM initiated coverage on Core Scientific with a new price target

      ROTH MKM initiated coverage of Core Scientific with a rating of Buy and set a new price target of $25.50

      11/15/24 7:41:45 AM ET
      $CORZ
      Finance: Consumer Services
      Finance

    $CORZ
    SEC Filings

    See more
    • Core Scientific Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Core Scientific, Inc./tx (0001839341) (Filer)

      5/13/25 4:04:31 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • SEC Form 10-Q filed by Core Scientific Inc.

      10-Q - Core Scientific, Inc./tx (0001839341) (Filer)

      5/7/25 5:00:06 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • Core Scientific Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Core Scientific, Inc./tx (0001839341) (Filer)

      5/7/25 4:09:34 PM ET
      $CORZ
      Finance: Consumer Services
      Finance

    $CORZ
    Leadership Updates

    Live Leadership Updates

    See more
    • Core Scientific Announces Strategic Marketing Hire to Accelerate Growth and Brand Leadership

      Industry Veteran Scott Brueggeman Joins Core Scientific as Chief Marketing Officer to Drive Market Expansion and Visibility Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or "the Company"), a leader in digital infrastructure for high-performance computing and digital asset mining, today announced the appointment of Scott Brueggeman as Chief Marketing Officer. With over 20 years of experience in digital infrastructure and technology businesses, Brueggeman will play a pivotal role in strengthening the company's brand presence, driving growth, and expanding market opportunities. Brueggeman brings a proven track record of success in high-growth environments. Most recently, he served

      1/9/25 8:00:00 AM ET
      $CORZ
      Finance: Consumer Services
      Finance